Skip to Main Content

Paper Details

Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes.
Nat Commun
62
2021
ACE2, ACE2-binding sites, Cass III, Nb, Nbs, RBD, RBD Nbs, SARS-CoV, SARS-CoV-2, SARS-CoV-2 spike, epitopes, severe acute respiratory syndrome coronavirus, severe acute respiratory syndrome coronavirus 2
Author NameAffiliation
Derek J TaylorCase Western Reserve University
Derek J TaylorCase Western Reserve University
Dina Schneidman-DuhovnyInstitute of Life Sciences, The Hebrew University of 6
Dina Schneidman-DuhovnyInstitute of Life Sciences, The Hebrew University of 6
Yi ShiThe University of Pittsburgh and Carnegie Mellon University Program for Computational Biology
Yi ShiUniversity of Pittsburgh
Yi ShiUniversity of Pittsburgh School of Medicine and Carnegie Mellon University
  • 1 - 7

Datasets

Release 1.2